DK0891778T3 - TCF-II til forebyggelse og/eller behandling af stråleinducerede lidelser - Google Patents

TCF-II til forebyggelse og/eller behandling af stråleinducerede lidelser

Info

Publication number: DK0891778T3
Authority: DK; Denmark
Prior art keywords: tcf; prevention; radiation; treatment; induced disorders
Prior art date: 1997-07-14

Application number

DK98112761T

Other languages

English (en)

Inventor

Yoshio Arai

Original Assignee

Daiichi Seiyaku Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-07-14

Filing date

1998-07-09

Publication date

2004-08-09

1998-07-09 Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co

2004-08-09 Application granted granted Critical

2004-08-09 Publication of DK0891778T3 publication Critical patent/DK0891778T3/da

Links

208000019095 Radiation-induced disease Diseases 0.000 title abstract 2
230000002265 prevention Effects 0.000 title abstract 2
206010028980 Neoplasm Diseases 0.000 abstract 1
108010094028 Prothrombin Proteins 0.000 abstract 1
AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 abstract 1
231100000433 cytotoxic Toxicity 0.000 abstract 1
230000001472 cytotoxic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Gastroenterology & Hepatology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Zoology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Hematology (AREA)
Diabetes (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK98112761T 1997-07-14 1998-07-09 TCF-II til forebyggelse og/eller behandling af stråleinducerede lidelser DK0891778T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP9188384A JPH1129493A (ja)	1997-07-14	1997-07-14	放射線障害予防及び／又は治療剤

Publications (1)

Publication Number	Publication Date
DK0891778T3 true DK0891778T3 (da)	2004-08-09

Family

ID=16222690

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK98112761T DK0891778T3 (da)	1997-07-14	1998-07-09	TCF-II til forebyggelse og/eller behandling af stråleinducerede lidelser

Country Status (11)

Country	Link
US (1)	US5998370A (da)
EP (1)	EP0891778B1 (da)
JP (1)	JPH1129493A (da)
KR (1)	KR100564353B1 (da)
AT (1)	ATE269714T1 (da)
AU (1)	AU732053B2 (da)
CA (1)	CA2242559A1 (da)
DE (1)	DE69824670T2 (da)
DK (1)	DK0891778T3 (da)
ES (1)	ES2219810T3 (da)
ZA (1)	ZA986090B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69531673T2 (de) *	1994-12-27	2004-07-08	Daiichi Pharmaceutical Co., Ltd.	Tcf mutante
JP4006058B2 (ja)	1997-03-11	2007-11-14	第一三共株式会社	多臓器不全予防及び／又は治療剤
ES2274567T3 (es)	1997-03-14	2007-05-16	Daiichi Pharmaceutical Co., Ltd.	Utilizacion de tcf-ii para el tratamiento de la perdida de peso corporal, la anemia y la elevacion de tnf causadas por el cancer.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ232813A (en) *	1989-03-10	1992-08-26	Snow Brand Milk Products Co Ltd	Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
AU674871B2 (en) *	1992-07-16	1997-01-16	Atlas Pharmaceuticals Inc.	Blood coagulation normalizer containing TCF-II as active ingredient
DK0588477T3 (da) *	1992-07-16	1998-03-30	Snow Brand Milk Products Co Ltd	Medicinsk præparat omfatende TCF-11
DE69310525T2 (de) *	1992-09-16	1997-10-02	Genentech Inc	Schutz gegen leberschäden mit hgf
NZ298141A (en) *	1994-12-27	2000-12-22	Snow Brand Milk Products Co Ltd	Treating lipid metabolism disorder using TCF-II
JP4006058B2 (ja) *	1997-03-11	2007-11-14	第一三共株式会社	多臓器不全予防及び／又は治療剤
ES2274567T3 (es) *	1997-03-14	2007-05-16	Daiichi Pharmaceutical Co., Ltd.	Utilizacion de tcf-ii para el tratamiento de la perdida de peso corporal, la anemia y la elevacion de tnf causadas por el cancer.

1997
- 1997-07-14 JP JP9188384A patent/JPH1129493A/ja active Pending
1998
- 1998-07-06 AU AU74174/98A patent/AU732053B2/en not_active Ceased
- 1998-07-07 CA CA002242559A patent/CA2242559A1/en not_active Abandoned
- 1998-07-08 KR KR1019980027414A patent/KR100564353B1/ko not_active Expired - Fee Related
- 1998-07-09 DK DK98112761T patent/DK0891778T3/da active
- 1998-07-09 DE DE69824670T patent/DE69824670T2/de not_active Expired - Fee Related
- 1998-07-09 AT AT98112761T patent/ATE269714T1/de not_active IP Right Cessation
- 1998-07-09 EP EP98112761A patent/EP0891778B1/en not_active Expired - Lifetime
- 1998-07-09 ZA ZA986090A patent/ZA986090B/xx unknown
- 1998-07-09 ES ES98112761T patent/ES2219810T3/es not_active Expired - Lifetime
- 1998-07-14 US US09/115,294 patent/US5998370A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
KR19990013676A (ko)	1999-02-25
ZA986090B (en)	1999-04-20
DE69824670D1 (de)	2004-07-29
CA2242559A1 (en)	1999-01-14
AU732053B2 (en)	2001-04-12
KR100564353B1 (ko)	2006-09-18
AU7417498A (en)	1999-01-21
EP0891778A3 (en)	2000-01-26
DE69824670T2 (de)	2004-12-09
EP0891778B1 (en)	2004-06-23
ATE269714T1 (de)	2004-07-15
US5998370A (en)	1999-12-07
EP0891778A2 (en)	1999-01-20
ES2219810T3 (es)	2004-12-01
JPH1129493A (ja)	1999-02-02

Similar Documents

Publication	Publication Date	Title
DE69817796D1 (de)	2003-10-09	Verriegelungs- und belüftungssystem zum oxidativen desinfizieren von kontaktlinsen
DE69112515D1 (de)	1995-10-05	UV-härtbare Siliconzusammensetzung.
NO981501D0 (no)	1998-04-02	Dimer-selektive RXR modulatorer og fremgangsmåter for anvendelse derav
DK0921785T3 (da)	2005-04-18	Kombination af syreproteaseenzymer og sure puffere og anvendelser deraf
DK0833649T4 (da)	2009-07-20	Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier
FI935555A0 (fi)	1993-12-10	Nya sulfonamider
DK0683780T3 (da)	2000-09-25	Imidazopyridiner og deres anvendelse til behandling af mave-tarm-sygdomme
FI931250A0 (fi)	1993-03-22	Sulfonamido- och sulfonamidokarbonyl-pyridin-2-karboxylsyraamider och deras pyridin-n-oxider, foerfarande foer deras framstaellning och deras anvaendning som laekemedel
DK0634175T3 (da)	2001-04-30	Farmaceutisk kombination, der indeholder en hæmmer af renin-angiotensin-systemet og en endothelin-antagonist
FI944770A0 (fi)	1994-10-11	Neurotensiiniin vaikuttavia substituoituja 1-naftyylipyratsoli-3-karboksiamideja, niiden valmistus ja niitä sisältäviä farmaseuttisia koostumuksia
DK0674902T3 (da)	2007-07-23	Sammensætninger til forbedring af immunreaktionen
DK0638068T3 (da)	1999-11-22	Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner
CA2217551A1 (en)	1999-01-03	Photoactivated hypericin and the use thereof
DK631989D0 (da)	1989-12-14	Anti-plakmiddel og/eller middel til behandling af lidelser i mundhulen
ZA986090B (en)	1999-04-20	Agents for the prevention and/or treatment of radiation-induced disorders
FI874450A0 (fi)	1987-10-09	Farmaceutiska sammansaettningar vid terapin av hjaernsjukdomar pao funktionell och organisk bas.
ITMI913466A0 (it)	1991-12-23	Procedimento per la depurazione dell'1.1.1-trifluoro-2-fluoroetano e dell'1.1.1-trifuoro-2,2-diocloroetano
DK0834316T3 (da)	2002-08-05	Anvendelse af sulbutiamin til behandling af psykomotoriske eller psykointellektuelle problemer
RU97115054A (ru)	1999-02-20	Средство для лечения онкологических больных
IT1320401B1 (it)	2003-11-26	Procedimento per la fabbricazione di componenti di un'ossatura ecomponenti di ossatura.
ITRM930259A0 (it)	1993-04-23	Procedimento per la purificazione e stabilizzazione di perfluoropolieteri.
DK1064014T3 (da)	2005-05-30	Lægemiddel til forebyggelse eller behandling af papillomvirusspecifik tumor
BR9710992A (pt)	2000-10-24	Derivados anticovulsivos úteis no tratamento de psorìase
HUP9901488A2 (hu)	1999-08-30	Kontrasztanyagok
ITTO980741A0 (it)	1998-09-03	Procedimento di preparazione di composti del tipo arilamminoalchilidenemalonati.